Younes Maged, Aquilina Gabriele, Castle Laurence, Degen Gisela, Engel Karl-Heinz, Fowler Paul J, Frutos Fernandez Maria Jose, Fürst Peter, Gundert-Remy Ursula, Gürtler Rainer, Husøy Trine, Manco Melania, Passamonti Sabina, Moldeus Peter, Shah Romina, Waalkens-Berendsen Ine, Wright Matthew, Benigni Romualdo, Bolognesi Claudia, Chipman Kevin, Cordelli Eugenia, Nørby Karin, Svendsen Camilla, Carfì Maria, Mennes Wim
EFSA J. 2023 Feb 13;21(2):e07777. doi: 10.2903/j.efsa.2023.7777. eCollection 2023 Feb.
The Panel on Food additives and Flavourings (FAF) was requested to evaluate the flavouring substances 2,4-dimethyl-3-thiazoline [FL-no: 15.060] and 2-isobutyl-3-thiazoline [FL-no: 15.119] in Flavouring Group Evaluation 21 revision 6 (FGE.21Rev6). FGE.21Rev6 deals with 41 flavouring substances of which 39 have been already evaluated to be of no safety concern when based on the MSDI approach. For [FL-no: 15.060 and 15.119], a concern for genotoxicity was raised in FGE.21. Genotoxicity data have been submitted for the supporting substance 4,5-dimethyl-2-isobutyl-3-thiazoline [FL-no: 15.032] evaluated in FGE.76Rev2. The concerns for gene mutations and clastogenicity are ruled out for [FL-no: 15.032] and for the structurally related substances [FL-no: 15.060 and 15.119], but not for aneugenicity. Therefore, the aneugenic potential of [FL-no: 15.060 and 15.119] should be investigated in studies with the individual substances. For [FL-no: 15.054, 15.055, 15.057, 15.079 and 15.135], (more reliable) information on uses and use levels is needed to (re)calculate the mTAMDIs in order to finalise their evaluation. Provided that information is submitted for [FL-no: 15.060 and 15.119] with respect to potential aneugenicity, that would allow evaluation of these substances through the Procedure, also for these two substances, more reliable data on uses and use levels would be required. Upon submission of such data, additional data on toxicity may become necessary for all seven substances. For [FL-no: 15.054, 15.057, 15.079 and 15.135], information on the actual percentages of stereoisomers in the material of commerce based on analytical data should be provided.
食品添加剂和调味剂专家委员会(FAF)被要求对调味剂组评估21修订版6(FGE.21Rev6)中的调味物质2,4 - 二甲基 - 3 - 噻唑啉[FL编号:15.060]和2 - 异丁基 - 3 - 噻唑啉[FL编号:15.119]进行评估。FGE.21Rev6涉及41种调味物质,其中39种基于最大每日摄入量(MSDI)方法已被评估为无安全问题。对于[FL编号:15.060和15.119],FGE.21中提出了对遗传毒性的担忧。已提交了在FGE.76Rev2中评估的支持物质4,5 - 二甲基 - 2 - 异丁基 - 3 - 噻唑啉[FL编号:15.032]的遗传毒性数据。对于[FL编号:15.032]以及结构相关物质[FL编号:15.060和15.119],基因突变和致染色体断裂性方面的担忧已被排除,但非整倍体形成性方面的担忧未被排除。因此,应使用各单独物质进行研究,以调查[FL编号:15.060和15.119]的非整倍体形成潜力。对于[FL编号:15.054、15.055、15.057、15.079和15.135],需要(更可靠的)关于使用情况和使用水平的信息,以(重新)计算最大理论平均每日摄入量(mTAMDIs),从而完成对它们的评估。如果提交了关于[FL编号:15.060和15.119]潜在非整倍体形成性的信息,这将允许通过该程序对这些物质进行评估,同样对于这两种物质,也需要更可靠的关于使用情况和使用水平的数据。提交此类数据后,可能需要所有七种物质的更多毒性数据。对于[FL编号:15.054、15.057、15.079和15.135],应根据分析数据提供商业材料中立体异构体实际百分比的信息。